273 related articles for article (PubMed ID: 24391502)
1. Group B Streptococcus engages an inhibitory Siglec through sialic acid mimicry to blunt innate immune and inflammatory responses in vivo.
Chang YC; Olson J; Beasley FC; Tung C; Zhang J; Crocker PR; Varki A; Nizet V
PLoS Pathog; 2014 Jan; 10(1):e1003846. PubMed ID: 24391502
[TBL] [Abstract][Full Text] [Related]
2. Dual actions of group B
Uchiyama S; Sun J; Fukahori K; Ando N; Wu M; Schwarz F; Siddiqui SS; Varki A; Marth JD; Nizet V
Proc Natl Acad Sci U S A; 2019 Apr; 116(15):7465-7470. PubMed ID: 30910970
[TBL] [Abstract][Full Text] [Related]
3. Sialic Acid-Siglec-E Interactions Regulate the Response of Neonatal Macrophages to Group B Streptococcus.
Lund SJ; Del Rosario PGB; Honda A; Caoili KJ; Hoeksema MA; Nizet V; Patras KA; Prince LS
Immunohorizons; 2024 May; 8(5):384-396. PubMed ID: 38809232
[TBL] [Abstract][Full Text] [Related]
4. Sialic Acid-Siglec-E Interactions During
Mukherjee K; Khatua B; Mandal C
Front Immunol; 2020; 11():332. PubMed ID: 32184783
[No Abstract] [Full Text] [Related]
5. Role of macrophage sialoadhesin in host defense against the sialylated pathogen group B Streptococcus.
Chang YC; Olson J; Louie A; Crocker PR; Varki A; Nizet V
J Mol Med (Berl); 2014 Sep; 92(9):951-9. PubMed ID: 24788876
[TBL] [Abstract][Full Text] [Related]
6. Siglec-5 and Siglec-14 are polymorphic paired receptors that modulate neutrophil and amnion signaling responses to group B Streptococcus.
Ali SR; Fong JJ; Carlin AF; Busch TD; Linden R; Angata T; Areschoug T; Parast M; Varki N; Murray J; Nizet V; Varki A
J Exp Med; 2014 Jun; 211(6):1231-42. PubMed ID: 24799499
[TBL] [Abstract][Full Text] [Related]
7. Group B Streptococcus suppression of phagocyte functions by protein-mediated engagement of human Siglec-5.
Carlin AF; Chang YC; Areschoug T; Lindahl G; Hurtado-Ziola N; King CC; Varki A; Nizet V
J Exp Med; 2009 Aug; 206(8):1691-9. PubMed ID: 19596804
[TBL] [Abstract][Full Text] [Related]
8. Molecular mimicry of host sialylated glycans allows a bacterial pathogen to engage neutrophil Siglec-9 and dampen the innate immune response.
Carlin AF; Uchiyama S; Chang YC; Lewis AL; Nizet V; Varki A
Blood; 2009 Apr; 113(14):3333-6. PubMed ID: 19196661
[TBL] [Abstract][Full Text] [Related]
9. Siglec-14 Enhances NLRP3-Inflammasome Activation in Macrophages.
Tsai CM; Riestra AM; Ali SR; Fong JJ; Liu JZ; Hughes G; Varki A; Nizet V
J Innate Immun; 2020; 12(4):333-343. PubMed ID: 31805552
[TBL] [Abstract][Full Text] [Related]
10. A soluble form of Siglec-9 provides a resistance against Group B Streptococcus (GBS) infection in transgenic mice.
Saito M; Yamamoto S; Ozaki K; Tomioka Y; Suyama H; Morimatsu M; Nishijima KI; Yoshida SI; Ono E
Microb Pathog; 2016 Oct; 99():106-110. PubMed ID: 27544323
[TBL] [Abstract][Full Text] [Related]
11. Interaction of Group B Streptococcus sialylated capsular polysaccharides with host Siglec-like molecules dampens the inflammatory response in tilapia.
Dong J; Wei Y; Sun C; Tian Y; Hu J; Shi H; Zhang D; Lu M; Ye X
Mol Immunol; 2018 Nov; 103():182-190. PubMed ID: 30291999
[TBL] [Abstract][Full Text] [Related]
12. Engagement of myelomonocytic Siglecs by tumor-associated ligands modulates the innate immune response to cancer.
Läubli H; Pearce OM; Schwarz F; Siddiqui SS; Deng L; Stanczak MA; Deng L; Verhagen A; Secrest P; Lusk C; Schwartz AG; Varki NM; Bui JD; Varki A
Proc Natl Acad Sci U S A; 2014 Sep; 111(39):14211-6. PubMed ID: 25225409
[TBL] [Abstract][Full Text] [Related]
13. Exploring the Impact of Ketodeoxynonulosonic Acid in Host-Pathogen Interactions Using Uptake and Surface Display by Nontypeable Haemophilus influenzae.
Saha S; Coady A; Sasmal A; Kawanishi K; Choudhury B; Yu H; Sorensen RU; Inostroza J; Schoenhofen IC; Chen X; Münster-Kühnel A; Sato C; Kitajima K; Ram S; Nizet V; Varki A
mBio; 2021 Jan; 12(1):. PubMed ID: 33468699
[TBL] [Abstract][Full Text] [Related]
14. Group B streptococcal capsular sialic acids interact with siglecs (immunoglobulin-like lectins) on human leukocytes.
Carlin AF; Lewis AL; Varki A; Nizet V
J Bacteriol; 2007 Feb; 189(4):1231-7. PubMed ID: 16997964
[TBL] [Abstract][Full Text] [Related]
15. Discovery and expression of 3 siglecs-like in Oreochromis niloticus neutrophil, and their interaction with group B streptococcal sialylated capsular polysaccharides.
Dong J; Wei Y; Ye X; Sun C; Tian Y; Lu M; Du J; Chen Z
Mol Immunol; 2016 May; 73():158-69. PubMed ID: 26847490
[TBL] [Abstract][Full Text] [Related]
16. Paired Siglec receptors generate opposite inflammatory responses to a human-specific pathogen.
Schwarz F; Landig CS; Siddiqui S; Secundino I; Olson J; Varki N; Nizet V; Varki A
EMBO J; 2017 Mar; 36(6):751-760. PubMed ID: 28100677
[TBL] [Abstract][Full Text] [Related]
17. Human Siglec-5 inhibitory receptor and immunoglobulin A (IgA) have separate binding sites in streptococcal beta protein.
Nordström T; Movert E; Olin AI; Ali SR; Nizet V; Varki A; Areschoug T
J Biol Chem; 2011 Sep; 286(39):33981-91. PubMed ID: 21795693
[TBL] [Abstract][Full Text] [Related]
18. Leishmania donovani Utilize Sialic Acids for Binding and Phagocytosis in the Macrophages through Selective Utilization of Siglecs and Impair the Innate Immune Arm.
Roy S; Mandal C
PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004904. PubMed ID: 27494323
[TBL] [Abstract][Full Text] [Related]
19. Siglecs at the Host-Pathogen Interface.
Chang YC; Nizet V
Adv Exp Med Biol; 2020; 1204():197-214. PubMed ID: 32152948
[TBL] [Abstract][Full Text] [Related]
20. Host and pathogen hyaluronan signal through human siglec-9 to suppress neutrophil activation.
Secundino I; Lizcano A; Roupé KM; Wang X; Cole JN; Olson J; Ali SR; Dahesh S; Amayreh LK; Henningham A; Varki A; Nizet V
J Mol Med (Berl); 2016 Feb; 94(2):219-33. PubMed ID: 26411873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
